arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

SkyAI, Inc.

SKYA Health Care Medical/Dental Instruments
$2.88
▲ +0.2% Today
as of Oct 23, 13:06 ET
Last 30 days +103.17% Sep 14 → Oct 23
$1.17 $1.63 $2.09 $2.55 $3.01 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.87
High
$2.89
Low
$2.84
Volume
$1M
Avg Vol
$594,098
Mkt Cap
$84M
P/E (TTM)
—
Beta
—
52w High
$5.49
52w Low
$0.91
Div Yield
—
Shares Out
$43M

Recent Press Releases & News last 60 days · 11 items

Oct 21 · 18:18 MT Newswires
SkyAI Shares Rise After Third Eye Backs Call to Improve Tender Offer Terms
Oct 20 · 15:00 24/7 Wall St.
SkyAI Sold Its Entire Solana Treasury as Bitmine Topped 6 Million ETH. Which Coin Is the Better Buy?
Oct 20 · 02:00 CryptoProwl
SkyAI Abandons Solana Treasury Strategy, Holds $223.8 Million in Cash for Buyback
▸ Show all 11 press releases & news Free account →

SKYA earnings at a glance

The options market is pricing a move of about ±174.6% after the report, a range of roughly -$2.15 to $7.91 from today's $2.88. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.6% on average; after the most recent report on May 14, 2026 it moved +2.0%. That means options currently expect more movement than SKYA has typically delivered. Implied volatility is currently 15%. The share price of $2.88 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.91
$5.49
43% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+0.5%
50% positive
Latest IV / EM
1478%
EM ±174.6% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-643.64$-473.07$-302.51$-131.94$38.62 Actual $-0.20Actual $0.22Actual $-3.77Actual $-347.50Actual $-643.64Actual $-379.55Actual $38.62Actual $3.58Actual $-4.02Actual $-1.19Actual $-0.32 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-105M$-78M$-51M$-24M$4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.32 — — — — financials
Thu May 14, 2026Mar/2026 $-1.19 — — -103.1% +2.0% earnings
Fri Nov 14, 2025Sep/2025 $-4.02 — — — — earnings
Wed Aug 13, 2025Jun/2025 $3.58 — — — — earnings
Thu May 15, 2025Mar/2025 $38.62 — — — -1.1% earnings
Mon Sep 30, 2024Sep 2024 $-379.55 — — — — financials
Sun Jun 30, 2024Jun 2024 $-643.64 — — — — financials
Sun Mar 31, 2024Mar 2024 $-347.50 — — — — financials
Sat Sep 30, 2023Sep 2023 $-3.77 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.22 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.20 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue—$192,780—$83,622$136,080———
Cost of revenue$284,228$202,578—$1M$148,620———
Gross profit$-284,228$-9,798—$-1M$-12,540———
Operating income$-23M$-86M—$-103M$-1M$-1M—$-2M
Net income$-23M$-86M—$-105M$4M$2M—$-2M
EPS (diluted)$-0.32$-1.19—$-4.33$3.58$38.63—$-379.55

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$12M$12M$10M$11M$8M$12M$864,041$2M
Inventory$173,481$457,709$645,268$745,261$2M$2M$2M$2M
Total current assets$16M$18M$19M$40M$10M$14M$3M$5M
Total assets$160M$181M$269M$444M$17M$19M$7M$11M
Long-term debt————————
Total liabilities$3M$2M$5M$11M$3M$9M$5M$5M
Total equity$157M$179M$264M$433M$15M$10M$2M$7M

Implied volatility — last 90 days

626%2659%4693%6727%8761% Jun 08 — IV 3160% · EM ±417.3%Jun 09 — IV 3922% · EM ±491.4%Jun 10 — IV 3127% · EM ±369.4%Jun 11 — IV 2603% · EM ±287.6%Jun 12 — IV 2487% · EM ±254.5%Jun 15 — IV 2763% · EM ±199.9%Jun 16 — IV 3675% · EM ±217.1%Jun 17 — IV 7982% · EM ±333.3%Jun 19 — IV 1131% · EM ±250.0%Jun 22 — IV 1352% · EM ±282.4%Jun 23 — IV 1400% · EM ±286.4%Jun 24 — IV 1738% · EM ±348.0%Jun 25 — IV 1881% · EM ±368.4%Jun 26 — IV 1701% · EM ±325.5%Jun 29 — IV 1940% · EM ±343.8%Jun 30 — IV 2354% · EM ±405.4%Jul 01 — IV 3182% · EM ±531.5%Jul 02 — IV 2920% · EM ±472.3%Jul 03 — IV 3044% · EM ±475.6%Jul 06 — IV 3406% · EM ±471.8%Jul 07 — IV 3819% · EM ±504.3%Jul 08 — IV 2170% · EM ±271.9%Jul 09 — IV 2870% · EM ±339.0%Jul 10 — IV 3121% · EM ±344.8%Jul 13 — IV 5514% · EM ±460.5%Jul 14 — IV 6316% · EM ±456.9%Jul 15 — IV 7100% · EM ±419.4%Jul 16 — IV 7847% · EM ±327.7%Jul 20 — IV 830% · EM ±196.2%Jul 21 — IV 796% · EM ±185.2%Jul 22 — IV 789% · EM ±180.5%Jul 23 — IV 705% · EM ±158.6%Jul 24 — IV 781% · EM ±172.7%Jul 27 — IV 907% · EM ±189.4%Jul 28 — IV 820% · EM ±167.9%Jul 29 — IV 893% · EM ±178.8%Jul 30 — IV 952% · EM ±186.6%Jul 31 — IV 997% · EM ±190.8%Aug 03 — IV 1116% · EM ±197.7%Aug 04 — IV 1117% · EM ±192.3%Aug 05 — IV 1216% · EM ±203.1%Aug 06 — IV 1480% · EM ±239.3%Aug 07 — IV 1481% · EM ±231.4%Aug 10 — IV 1559% · EM ±216.0%Aug 11 — IV 1860% · EM ±245.7%Aug 12 — IV 2067% · EM ±258.9%Aug 13 — IV 2667% · EM ±315.0%Aug 14 — IV 4664% · EM ±515.3%Aug 17 — IV 3711% · EM ±310.0%Aug 18 — IV 8761% · EM ±633.7%Aug 19 — IV 3522% · EM ±208.0%Aug 20 — IV 4902% · EM ±204.7%Aug 24 — IV 1379% · EM ±287.9%Aug 25 — IV 1378% · EM ±282.0%Aug 26 — IV 1533% · EM ±307.1%Aug 27 — IV 822% · EM ±161.1%Aug 28 — IV 1288% · EM ±246.5%Aug 31 — IV 1524% · EM ±270.1%Sep 01 — IV 1768% · EM ±304.5%Sep 02 — IV 1673% · EM ±279.5%Sep 03 — IV 1621% · EM ±262.2%Sep 04 — IV 997% · EM ±155.8%Sep 07 — IV 1125% · EM ±155.8%Sep 08 — IV 2027% · EM ±267.7%Sep 09 — IV 2289% · EM ±286.8%Sep 10 — IV 1661% · EM ±196.2%Sep 11 — IV 2495% · EM ±275.7%Sep 14 — IV 2276% · EM ±190.1%Sep 15 — IV 3770% · EM ±272.7%Sep 16 — IV 5002% · EM ±295.5%Sep 17 — IV 4113% · EM ±171.8%Sep 21 — IV 761% · EM ±159.0%Sep 22 — IV 947% · EM ±193.8%Sep 23 — IV 910% · EM ±182.3%Sep 24 — IV 962% · EM ±188.5%Sep 29 — IV 651% · EM ±112.0%Sep 30 — IV 814% · EM ±135.9%Oct 01 — IV 821% · EM ±132.8%Oct 02 — IV 626% · EM ±97.8%Oct 05 — IV 718% · EM ±99.4%Oct 06 — IV 844% · EM ±111.4%Oct 08 — IV 1478% · EM ±174.6%

Sector peers

LUNG
Pulmonx Corporation
$82M $1.80-1.6%
LNSR
LENSAR, Inc.
$80M $5.95+4.6%
SKIN
SkinHealth Systems Inc.
$77M $10.90-1.2%
GUTS
Fractyl Health, Inc.
$72M $1.09-5.2%
QTEX
QTREX Quantum Ltd.
$71M $1.38-11.0%
APYX
Apyx Medical Corporation
$107M $2.38-5.4%

SKYA earnings FAQ

What is SKYA's expected move for earnings?

Options currently price a move of about ±174.6%, or $5.03 per share either way from $2.88.

How does SKYA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.6%, up 1 times and down 1 times.

What is SKYA's implied volatility?

SKYA's at-the-money implied volatility is about 15% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in